Repaglinide
Cat. No.:YN481424
产品名称: | Repaglinide |
CAS No.: | 135062-02-1 |
Chemical Name: | 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-benzoic acid |
Synonyms: | 瑞格列奈; AG-EE 623ZW |
分子量: | 452.59 |
分子式: | C₂₇H₃₆N₂O₄ |
SMILES: | CC(C)C[C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)C2=CC=CC=C2N3CCCCC3 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Repaglinide 是用于2 型糖尿病的胰岛素促分泌剂 (insulin secretagogue)。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Hansen, A.M.K., Hansen, J.B., Carr, R.D., et al.Kir6.2-dependent high-affinity repaglinide binding to β-cell KATP channelsBr. J. Pharmacol.144(4),551-557(2005)
Mark, M., and Grell, W.Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogsBr. J. Pharmacol.121(8),1597-1604(1997)